Key facts
- This page summarizes Robert M. Gervis's Form 4 filing for ASPEN AEROGELS INC (ASPN).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Jun 2022, 19:06.
Robert M. Gervis - 02 Jun 2022 Form 4 Insider Report for ASPEN AEROGELS INC (ASPN)
- Reporting relationship
- Director
- Issuer ticker
- ASPN
- Reported as of
- 02 Jun 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Jun 2022, 19:06:08 UTC
- Prior SEC filing
- 23 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Poongunran Muthukumaran, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert M. Gervis filed Form 4 for ASPEN AEROGELS INC (ASPN) on 06 Jun 2022.
Change
- Previous filing in this sequence was filed on 23 Mar 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASPN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,699
- Change %
- +0.77%
- Price
- $0.000000
- Shares after
- 355,182
- Date
- 02 Jun 2022
- Ownership
- Direct
- Footnotes
- F1
ASPN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 72,491
- Date
- 02 Jun 2022
- Ownership
- Held by Robert Gervis 2014 Grantor Retained Annuity Trust
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ASPN
transaction
Derivative
Stock Option (Right-to-Buy)
Award
- Transaction value
- $0
- Shares
- +3,178
- Change %
- Price
- $0.000000
- Shares after
- 3,178
- Date
- 02 Jun 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,178
- Exercise price
- $18.89
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The reporting person was granted restricted shares of common stock representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. These restricted shares will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023.
Footnote F2
Represents shares held by the Robert Gervis 2014 Grantor Retained Annuity Trust, of which the reporting person is a beneficiary and his spouse is trustee.
Footnote F3
The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) June 2, 2023, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2023.